WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading

FRIDAY, March 14, 2025 (HealthDay News) — A muscle-stimulating implant combined with a robotic exoskeleton can help restore movement in people paralyzed by a spinal cord injury, a new study says. The spinal cord implant delivers well-timed electrical pulses to muscles, stimulating natural muscle activity coordinated with supportive robotic movements,Continue Reading